4 photos
-
Figure 1: The typical drug development and approval process
- Uploaded by: U.S. Government Accountability Office
- License: United States Government Work
- 0 comments
- 2 favorites
- 24,091 views
- Date uploaded: 2020-02-03
- Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao20215sp, artificialintelligenceinhealthcare, ai, artificialintelligence, fda, foodanddrugadministration, hipaa, healthinsuranceportabilityandaccountabilityactof1996, ind, investigationalnewdrugapplication, melloddy, machinelearningledgerorchestrationfordrugdiscovery, mlpds, machinelearningforpharmaceuticaldiscoveryandsynthesisconsortium, nda, newdrugapplication, ncats, nationalcenterforadvancingtranslationalsciences, nih, nationalinstitutesofhealth, rd, researchanddevelopment, nationalacademyofmedicine, nam, technologyassessment
- Visibility: public
-
Figure 2: The lock and key analogy for drug-target interactions
- Uploaded by: U.S. Government Accountability Office
- License: United States Government Work
- 0 comments
- 0 favorites
- 16,162 views
- Date uploaded: 2020-02-03
- Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao20215sp, artificialintelligenceinhealthcare, ai, artificialintelligence, fda, foodanddrugadministration, hipaa, healthinsuranceportabilityandaccountabilityactof1996, ind, investigationalnewdrugapplication, melloddy, machinelearningledgerorchestrationfordrugdiscovery, mlpds, machinelearningforpharmaceuticaldiscoveryandsynthesisconsortium, nda, newdrugapplication, ncats, nationalcenterforadvancingtranslationalsciences, nih, nationalinstitutesofhealth, rd, researchanddevelopment, nationalacademyofmedicine, nam, technologyassessment
- Visibility: public
-
Figure 4: Machine learning could accelerate drug development
- Uploaded by: U.S. Government Accountability Office
- License: United States Government Work
- 0 comments
- 0 favorites
- 13,504 views
- Date uploaded: 2020-02-03
- Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao20215sp, artificialintelligenceinhealthcare, ai, artificialintelligence, fda, foodanddrugadministration, hipaa, healthinsuranceportabilityandaccountabilityactof1996, ind, investigationalnewdrugapplication, melloddy, machinelearningledgerorchestrationfordrugdiscovery, mlpds, machinelearningforpharmaceuticaldiscoveryandsynthesisconsortium, nda, newdrugapplication, ncats, nationalcenterforadvancingtranslationalsciences, nih, nationalinstitutesofhealth, rd, researchanddevelopment, nationalacademyofmedicine, nam, technologyassessment
- Visibility: public
-
Figure 5: Challenges hindering the use of machine learning in drug development
- Uploaded by: U.S. Government Accountability Office
- License: United States Government Work
- 0 comments
- 0 favorites
- 10,625 views
- Date uploaded: 2020-02-03
- Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao20215sp, artificialintelligenceinhealthcare, ai, artificialintelligence, fda, foodanddrugadministration, hipaa, healthinsuranceportabilityandaccountabilityactof1996, ind, investigationalnewdrugapplication, melloddy, machinelearningledgerorchestrationfordrugdiscovery, mlpds, machinelearningforpharmaceuticaldiscoveryandsynthesisconsortium, nda, newdrugapplication, ncats, nationalcenterforadvancingtranslationalsciences, nih, nationalinstitutesofhealth, rd, researchanddevelopment, nationalacademyofmedicine, nam, technologyassessment
- Visibility: public